[1] |
Vincent A.Immunology of disorders of neuromuscular transmission[J]. Acta Neurol Scand Suppl, 2006, 183:1-7.
|
[2] |
Lindstrom JM,Seybold ME,Lennon VA,et al.Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value[J]. Neurology, 1998, 51(4):933-939.
|
[3] |
Feng HY, Wang HY, Liu WB, et al.The high frequency and clinical feature of seronegative myasthenia gravis in Southern China[J].Neurol Sci,2013,34(6):919-924.
|
[4] |
Pasutharnchat N, Wacharapluesadee S,Hemachudha T.Clinical manifestations of acetylcholine receptor antibody positive and negative myasthenia gravis[J].J Med Assoc Thai,2012,95(3):313-319.
|
[5] |
Mossman S, Vincent A, Newsom-Davis J.Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity[J]. Lancet, 1986,1:116-119.
|
[6] |
Vincent A, Li Z, Hart A, et al.Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function[J]. Ann N Y Acad Sci, 1993, 681:529-538.
|
[7] |
Itoh H, Shibata K, Nitta S.Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis[J]. Br J Anaesth, 2001, 87(6):885-889.
|
[8] |
Cheng CA, Aun CS, Gin T.Comparison of rocuronium and suxamethonium for rapid tracheal intubation in children[J]. Paediatr Anaesth, 2002, 12(2):140-145.
|
[9] |
Sungur Ulke Z, Yavru A, Camci E,et al.Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy[J].Acta Anaesthesiol Scand, 2013,57(6):745-748.
|
[10] |
刘力,闵苏,魏珂.七氟醚和异氟醚对不同浓度罗库溴铵抑制乙酰胆碱受体内向电流的影响[J]. 中国药理学通报,2011,27(1):113-116.
|
[11] |
秦雪梅,鲁卫华,金孝岠,等.罗库溴铵用于重症肌无力患者胸腺切除术的肌松效应[J].中国临床药理学与治疗学, 2012,17(11): 1263-1270.
|
[12] |
McDonald T, Hoffman WE, Berkowitz R, et al. Heart rate variability and plasma catecholamines in patients during opioid detoxification[J].J Neurosurg Anesthesiol,1999,11(3):195-199.
|
[13] |
Moss J.Muscle relaxants and histamine release[J].Acta Anaesthesiol Scand, 1995,106( Suppl),7-12.
|
[14] |
Kido K, Uchida T, Makita K.A case of prolonged neuromuscular blockade possibly related to a high anti-acetylcholine receptor antibody level[J]. Masui, 2013, 62(4):445-448.
|
[15] |
Nilsson E, Meretoja OA.Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis[J]. Anesthesiology, 1990, 73:28-32.
|
[16] |
Mann R, Blobner M, Jelen-Esselborn S, et al.Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients[J]. Anesthesiology, 2000, 93(2):346-350.
|
[17] |
Huang WX, Huang P, Fredrikson S, et al.Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis[J]. Eur J Neurol, 2000, 7(2):195-202.
|
[18] |
Itoh H, Shibata K, Nitta S.Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis[J]. Anesth Analg, 2002, 95(1):109-113.
|